Medicenna Therapeutics Corp. MDNAF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.67M | -3.09M | -3.13M | -3.55M | -3.56M |
| Total Depreciation and Amortization | 12.30K | 10.20K | 11.50K | 16.70K | 13.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.70K | -1.77M | -575.30K | 32.70K | 14.50K |
| Change in Net Operating Assets | 467.40K | 1.58M | 132.70K | -88.60K | 970.70K |
| Cash from Operations | -3.20M | -3.26M | -3.56M | -3.58M | -2.56M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 1.40K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 1.40K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -20.00K | -20.00K | -19.00K | -19.00K | -13.00K |
| Issuance of Common Stock | 3.90M | 0.00 | 0.00 | 0.00 | 52.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.80M | -14.60K | -13.60K | -13.80K | 28.20K |
| Foreign Exchange rate Adjustments | -5.10K | 96.20K | -109.00K | 177.90K | -629.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -404.60K | -3.18M | -3.68M | -3.42M | -3.16M |